BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15540535)

  • 1. [Screening, prevention and early therapy of type 2 diabetics].
    Hanefeld M; Köhler C
    MMW Fortschr Med; 2004 Sep; 146(35-36):28-9, 31. PubMed ID: 15540535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to prevent type 2 diabetes.
    Abuissa H; Bel DS; O'keefe JH
    Curr Med Res Opin; 2005 Jul; 21(7):1107-14. PubMed ID: 16004680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can type 2 diabetes mellitus be considered preventable?
    Jermendy G
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S73-81. PubMed ID: 15955380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of type 2 diabetes: where do we stand?].
    Waeber G; Vollenweider P
    Rev Med Suisse; 2007 Jan; 3(96):291-5. PubMed ID: 17319400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy in prediabetes.
    Mukhopadhyay P; Chowdhury S
    J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contemporary prospects of prevention of type 2 diabetes mellitus].
    Zeman M; Zák A
    Cas Lek Cesk; 2005; 144(3):147-51. PubMed ID: 15887394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corner points of antihypertensive therapy in prediabetic state. Success with a combination].
    MMW Fortschr Med; 2003 Jul; 145(27-28):53. PubMed ID: 14587192
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?
    Swanson A; Watrin K; Wilder L
    J Fam Pract; 2010 Sep; 59(9):532-3. PubMed ID: 20824232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significant reduction of vascular risk factors within the framework of the population-based intervention project INVADE--a 2-year follow-up study].
    Sander K; Schulze Horn C; Briesenick C; Sander D
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1853-9. PubMed ID: 16915545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of type 2 diabetes--an overview].
    Qvigstad E
    Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3047-50. PubMed ID: 15586184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing type 2 diabetes: can we make the evidence work?
    Yates T; Davies M; Khunti K
    Postgrad Med J; 2009 Sep; 85(1007):475-80. PubMed ID: 19734515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.